Naganuma, Makoto http://orcid.org/0000-0002-4244-3243
,
Sugimoto, Shinya
Suzuki, Hideo
Matsuno, Yuichi
Araki, Toshimitsu
Shimizu, Hirotaka
Hayashi, Ryohei
Fukuda, Tomohiro
Nakamoto, Nobuhiro
Iijima, Hideki
Nakamura, Shiro
Kataoka, Masaharu
Tamura, Yuichi
Tatsumi, Koichiro
Hibi, Toshifumi
Suzuki, Yasuo
Kanai, Takanori
Article History
Received: 13 March 2019
Accepted: 26 April 2019
First Online: 17 May 2019
Compliance with ethical standards
:
: MN received commercial research funds from EA pharma Co., Ltd. and Mochida Pharmaceutical Co., Ltd., outside the submitted work. SN received lecture fees from Mitsubishi Tanabe Pharma Corp., AbbVie GK, Zeria Pharmaceutical co., Ltd., EA pharma Co., Ltd., and commercial research funds from Mitsubishi Tanabe Pharma Corp., AbbVie GK, EA pharma Co., Ltd., Kyorin Pharmaceutical Co., Ltd, JIMRO Co., Ltd., Otsuka Pharmaceutical Factory Inc., Takeda Pharmaceutical Co., Ltd, outside the submitted work. YS received lecture fees from Mitsubishi Tanabe Pharma Corp., AbbVie GK, Zeria Pharmaceutical co., Ltd., EA pharma Co., Ltd., Kyorin Pharmaceutical Co., Ltd. Janssen Japan Co., Ltd and commercial research funds from Mitsubishi Tanabe Pharma Corp., EA pharma Co., Ltd., AbbVie GK, EA pharma Co., Ltd., Kyorin Pharmaceutical Co., Ltd, AbbVie GK, JIMRO Co., Ltd., outside the submitted work. TK received lecture fees from Mitsubishi Tanabe Pharma Corp, Astellas Pharma Inc, Miyarisan Pharmaceutical Co., Ltd. AstraZeneca Plc, EA Pharma Co., Ltd., Kyorin Pharmaceutical Co., Ltd. and commercial research funds from AbbVie GK, Mochida Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Mitsubishi Tanabe Pharma Corp, Takeda Pharmaceutical Co., Ltd., Nihon Kayaku, Yakult Honsha Co., Ltd., Zeria Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Ono Pharmaceutical Co., Ltd., EA Pharma Co., Ltd., Ezaki Glico Co., Ltd. JIMRO Co., Ltd., EN Otsuka Pharmaceutical Co., Ltd, outside the submitted work.